Media coverage about Sigma-Aldrich (NASDAQ:SIAL) has trended somewhat negative on Friday, according to Accern. The research firm ranks the sentiment of news coverage by analyzing more than 20 million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Sigma-Aldrich earned a news sentiment score of -0.09 on Accern’s scale. Accern also assigned news articles about the specialty chemicals company an impact score of 45.2166675810847 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the next few days.

ILLEGAL ACTIVITY NOTICE: This article was first reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this article on another domain, it was illegally stolen and reposted in violation of U.S. & international trademark and copyright legislation. The original version of this article can be accessed at https://www.thecerbatgem.com/2017/09/08/sigma-aldrich-sial-given-daily-coverage-optimism-rating-of-0-09.html.

About Sigma-Aldrich

Sigma-Aldrich Corporation is a life science and high technology company. The Company develops, manufactures, purchases and distributes a range of biochemical and organic chemical products, kits and services that are used in scientific research. It manufactures and distributes around 250,000 chemicals, biochemical and other essential products and approximately 46,000 equipment products.

Insider Buying and Selling by Quarter for Sigma-Aldrich (NASDAQ:SIAL)

Receive News & Stock Ratings for Sigma-Aldrich Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sigma-Aldrich Co. and related stocks with our FREE daily email newsletter.